This was an excellent presentation. I liked the professor researching Exosomes as he gave a detailed but more general and 'semi-impartial' (he consults with RENE and other companies) view and understanding of them.
I thought Randolph came across very well. Obvious emthusiasm for the work and progress they are making and strong, solid science. One thing I did note that perhaps I hadn't fully appreciated before was that they establish the scalability early in the reseach so that they know it can be turned in to a product quickly and reliably if all trials prove the product works. While this takes extra time nearer the start of research, I think this is a very shrewd move as it allows build out of the research and final product based on very solid foundations.
This presentation has restored some faith (not that I ever really doubted the science), but I do wish they would pay more attention to the stare of the share price.
...deliver todays presentation 9 months ago...What a shame!
So much damage done to P I's due to poor leadership ....please stand down Olav and let your scientists and financial management take the company forward.
Been away for a few days. Not sure where all this negativity is coming from. I've always found Mol and Freddie to be excellent posters. The real venom should be directed at the RENE board who have let us all down completely over the last few years.
I have read mom's posts for several years. Mol doesn't speculate.....just reports, shares facts and knowledge...
100% reliable..... that's rare for aim.....keep it up please mol, as if we lost your input we may as well forget this site. Best wishes. Freddie
when have i ever professed to have said knowledge or ever tried to portray?
"Whereas the continual airing of your encyclopedic knowledge has done what, exactly?"
as to doing a proper analysis of ...historical ... price movements over time - jees
ain't hung up here nor anywhere else
as to belief....... moniker should give you a clue there
as your moniker would seem to suggest on your post today you do seem to be very sour
with seemingly my posts over time here - generally just info - up to you and everyone else to make of them as you will - presumably you read too much into them
that wasn't , nor is, my intention towards you or anyone else
Re "complete lack of knowledge of company":
Whereas the continual airing of your encyclopedic knowledge has done what, exactly?
The only way to trade this, or any other share, is by doing a proper analysis of price movements over time. There's absolutely no need to get hung up on what the company actually does. It's all about what the punters are willing to believe it does, and, as we see exemplified here, too much belief engenders the exact opposite of what the majority hopes for. It's just the way the market works.
Nice to hear that Randolph is to present a positive update on progress on exosomes research. Hopefully the market may soon realise the worth of their intellectual property. We now need to climb an unnecessarily steep hill back to status quo let's hope the update is really really good with a realistic 'achievable' timing plan!
"The data being presented at the ISCT 2018 conference represent a further advance in the development of our ExoPr0 exosome therapeutic candidate. We draw considerable encouragement from these new pre-clinical results and look forward to presenting further progress with the development of ExoPr0 as a potential new and highly novel cancer therapy in the months ahead."
"Reneneuron Group (LSE:RENE)Share price movements here risk proving similar to the new Marvel Avengers movie, essentially incomprehensible and capable of leaving those involved somewhat underwhelmed. Why didn't they mention the film was Episode 1 ..."
" RENEURON GROUP (LSE:RENE) Share price movements here risk proving similar to the new Marvel Avengers movie, essentially incomprehensible and capable of leaving those involved somewhat underwhelmed. Why didn't they mention the film was Episode ..."
Not quite as bad as all that Freddie. RENE is a science company , therefore scientists are central to it, though they should not be allowed out of control which has been the death of some companies.. Actually, I cannot see that they are. There is a very clear focus on the two large clinical trials - stroke and eyes - which promise to produce gold in approx 2-3 years. CLI was useful and can always be reactivated. However , there are a number of good competitors in that field , thus a correct decision was made to concentrate on the trials with the maximal potential.
Exosomes are in free of charge as is the patent bank.
The share price is pitiful of course and I share your frustrations over SIPPS. We should console ourselves with the thought that the company is - sort of - bid proof, insofar as the three main share holders - Woodford , Evans and WLS are unlikely to sell out for a low offer and are in for the long term . That term is actually a medium term when consideration of the fruition of RENE's efforts.
A point I have made before is that there is worldwide antipathy to bios at the moment. Yet it is changing . There have been some large American buyouts of CART companies recently- Juno and Kite - for huge sums . Consider that that money was shelled out for a technology which is not the best on the cancer immunology front ( Scancell far better). Stem cells remain loathed and the barrow boys of London and New York will not pay attention until the mood changes. When it does it is likely to be dramatic.
Hi mol. Thanks for the link. Have now read it in-depth. Its a shame Olav hasn't continued to share his Japanese market enthusiasm with us, investors, on a continued basis. This article is interesting and we can all guess that the US office is potentially a route into the Jap market place.
My concern is continued silence on core issues e.g. CLI, one of the three of the drug lines I invested in. All I get is a few snippets of other things the company has decided to involve themselves in. I dont need to list them as you and I are aware.
Timing plans appear irrelevant...the sprinkling of gold dust revenue stream is now not just tied up with the lisencing timing traffic jam but with challenging super duper purification equipment. If I had known I was investing in such a diverse and ever changing series of laboratory experiments I wouldnt have touched Rene with a barge pole. I've lost a fortune on this stock and have no idea when and where we are headed commercially. Guess the market feels the same and its reflected in the sp. My remaining Rene stock is held in a sipp containing the bones of ICX, Angel and a pitiful value of Rene. I'm sick of them and Olav as head of the pile must go as he is measured by share value and he has let his shareholders down....together with his brilliant scientists, who are clearly out of control as far as commercial issues are concerned
That's my lot. Just hoping another share I feel more informed about restored some of my losses....though no longer holding my breath with anything to do with aim!
To enable a management/board buyout at a significant discount?
Would that explain why the board have appeared reluctant to invest their own cash?
Additionally, Woodford has an over-sized holding - from 2015:
'Woodford Investment Management bought half the placing shares, and as a result its now owns 35.5% of the company, up from 26.63%.
The investment firm was granted a waiver so it does not have to make a mandatory offer as a result of the share subscription.'
Why invest at X when you can create Y.
Let's see some positive and sustained actions that benefit the business and ALL of its shareholders.
Important message from the Financial Conduct Authority:
Posting inside information that is not public knowledge, or information that is false or misleading, may constitute market abuse.
This could lead to an unlimited fine and up to seven years in prison.
If you have any information, concerns or queries about market abuse, click here.
The content of the messages posted represents the opinions of the author, and does not represent the opinions of Interactive Investor Trading Limited or its affiliates and has not been approved or issued by Interactive Investor Trading Limited.
You should be aware that the other participants of the above discussion group are strangers to you and may make statements which may be misleading, deceptive or wrong.
Please remember that the value of investments or income from them may go down as well as up and that the past performance of an investment is not a guide to its performance in the future.
The discussion boards on this site are intended to be an information sharing forum and is not intended to address your particular requirements.
Whilst information provided on them can help with your investment research you need to consider carefully whether you should make (or refraining from making) investment or other decisions based on what you see without doing further research on investments you are interested in.
Participating in this forum cannot be a substitute for obtaining advice from an appropriate expert independent adviser who takes into account your circumstances and specific investment needs in selected investments that are appropriate for you.